UK-based Ignota Labs has acquired all of the clinical-stage assets in Kronos Bio's pipeline, after the US company ceased operations earlier this year. Ignota specialises in turning around promising ...
Adam has interviewed over 1,000 finance experts since joining the CardRates team in 2016. He spearheads industry news coverage related to helping consumers achieve greater financial literacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback